Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,345,199
  • Shares Outstanding, K 227,649
  • Annual Sales, $ 1,477 M
  • Annual Income, $ 126,040 K
  • EBIT $ 115 M
  • EBITDA $ 128 M
  • 60-Month Beta 2.43
  • Price/Sales 2.64
  • Price/Cash Flow 69.29
  • Price/Book 9.55

Options Overview Details

View History
  • Implied Volatility 100.41% (-2.76%)
  • Historical Volatility 52.27%
  • IV Percentile 61%
  • IV Rank 47.94%
  • IV High 144.96% on 02/21/25
  • IV Low 59.38% on 12/31/25
  • Expected Move (DTE 6) 1.90 (8.27%)
  • Put/Call Vol Ratio 0.81
  • Today's Volume 218,552
  • Volume Avg (30-Day) 115,840
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 939,077
  • Open Int (30-Day) 891,251
  • Expected Range 21.12 to 24.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.04
  • Number of Estimates 6
  • High Estimate 0.09
  • Low Estimate -0.04
  • Prior Year 0.11
  • Growth Rate Est. (year over year) -63.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.12 +9.00%
on 02/06/26
36.45 -36.84%
on 01/07/26
-12.44 (-35.08%)
since 01/06/26
3-Month
21.12 +9.00%
on 02/06/26
42.70 -46.09%
on 11/10/25
-18.50 (-44.56%)
since 11/06/25
52-Week
21.12 +9.00%
on 02/06/26
72.98 -68.46%
on 02/19/25
-17.45 (-43.12%)
since 02/06/25

Most Recent Stories

More News
Stocks Roar Back as Beaten-Down Tech Sector Rebounds

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +1.97%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +2.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.15%. March E-mini S&P...

MSTR : 134.93 (+26.11%)
AMAT : 322.51 (+6.09%)
AVGO : 332.92 (+7.22%)
HIMS : 23.02 (-1.96%)
GLXY : 19.76 (+17.34%)
$IUXX : 25,075.77 (+2.15%)
COIN : 165.12 (+13.00%)
ASML : 1,413.01 (+4.66%)
ZNH26 : 112-035s (-0.01%)
ESH26 : 6,952.75s (+1.94%)
STX : 429.32 (+5.89%)
AMD : 208.44 (+8.28%)
Stocks Supported by Tech Strength and Improvement in Consumer Sentiment

The S&P 500 Index ($SPX ) (SPY ) today is up +1.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.93%. March E-mini S&P futures (ESH26...

MSTR : 134.93 (+26.11%)
AMAT : 322.51 (+6.09%)
AVGO : 332.92 (+7.22%)
HIMS : 23.02 (-1.96%)
GLXY : 19.76 (+17.34%)
$IUXX : 25,075.77 (+2.15%)
COIN : 165.12 (+13.00%)
ASML : 1,413.01 (+4.66%)
ZNH26 : 112-035s (-0.01%)
ESH26 : 6,952.75s (+1.94%)
AMD : 208.44 (+8.28%)
BILL : 48.94 (+37.16%)
Stocks Rebound on Positive Tech Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +1.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. March E-mini S&P futures (ESH26...

MSTR : 134.93 (+26.11%)
AMAT : 322.51 (+6.09%)
AVGO : 332.92 (+7.22%)
BE : 143.03 (+4.71%)
HIMS : 23.02 (-1.96%)
GLXY : 19.76 (+17.34%)
$IUXX : 25,075.77 (+2.15%)
COIN : 165.12 (+13.00%)
ZNH26 : 112-035s (-0.01%)
ESH26 : 6,952.75s (+1.94%)
WDC : 282.58 (+8.61%)
AMD : 208.44 (+8.28%)
Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion of its weight loss specialty by enabling providers to prescribe a Compounded...

HIMS : 23.02 (-1.96%)
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care

The company will offer access to Galleri ® , an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer

HIMS : 23.02 (-1.96%)
1 Volatile Stock for Long-Term Investors and 2 We Brush Off

1 Volatile Stock for Long-Term Investors and 2 We Brush Off

ANGI : 11.85 (+3.49%)
SPHR : 93.21 (+5.43%)
HIMS : 23.02 (-1.96%)
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2025 financial results after the market...

HIMS : 23.02 (-1.96%)
Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q3 Earnings?

Hims & Hers Health (HIMS): Buy, Sell, or Hold Post Q3 Earnings?

HIMS : 23.02 (-1.96%)
1 Healthcare Stock to Research Further and 2 Facing Headwinds

1 Healthcare Stock to Research Further and 2 Facing Headwinds

HIMS : 23.02 (-1.96%)
BLCO : 17.00 (+3.60%)
CNC : 38.46 (-3.66%)
Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over

New national spot “Rich People Live Longer” exposes America’s economically-driven health gap, declaring that access to life-changing care belongs to everyone

HIMS : 23.02 (-1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 26.55
2nd Resistance Point 25.08
1st Resistance Point 24.05
Last Price 23.02
1st Support Level 21.55
2nd Support Level 20.09
3rd Support Level 19.06

See More

52-Week High 72.98
Fibonacci 61.8% 53.17
Fibonacci 50% 47.05
Fibonacci 38.2% 40.93
Last Price 23.02
52-Week Low 21.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar